Jerry Richard Greenfield

Professor Jerry Richard Greenfield is a leading endocrinologist and clinical researcher affiliated with the University of New South Wales (Professor of Medicine) and St Vincent’s Hospital, where he serves as Head of the Endocrinology Department and Director of Diabetes Services. He also leads the St Vincent's Clinical Campus and contributes to academic governance as an Editorial Board member of Clinical Obesity and an Executive Council Member of the Australian Diabetes Society.

Education:

• MBBS and BSc Med, University of New South Wales (1995, with First Class Honours)
• PhD, Garvan Institute (2001-2004)
• FRACP (Royal Australian College of Physicians)

Research Interests: His work focuses on metabolic protection in obesity, monogenic diabetes, insulin resistance mechanisms, and the therapeutic potential of SGLT-2 inhibitors, GLP-1 receptor agonists, and dietary interventions like alkaline diets in diabetes management. Collaborative studies with St Vincent’s Department of Clinical Pharmacology explore pharmacogenetic interactions with metformin.

Grants and Research Funding: Over the past decade, he has secured significant grants (e.g., NHMRC Ideas Grants, Diabetes Australia Trust awards) for clinical trials on empagliflozin, metformin, and personalized phosphoproteomics in diabetes and obesity. His research spans type 1 and type 2 diabetes, lipodystrophies, and genetic obesity disorders.

Scientific Awards:

• 2020 Arc Postgraduate Council Research Supervisor Award
• 2017 Ranji and Amara Wikramanayake Clinical Diabetes Award
• 2010 Don Chisholm Fellowship, Garvan Institute
• 2005 PhD Thesis Prize, Garvan Institute
• 1989-1994 Inaugural Alumni Association Scholarship, UNSW

Labs and Collaborations: Based at the Garvan Institute of Medical Research and St Vincent’s Hospital, he collaborates with international institutions (e.g., University of Cambridge) and multidisciplinary teams in clinical pharmacology and diabetes research.